Phase 2 Readout~quarter

Phase 2 Readout: jade101

December 31, 2026

Company: Jade Biosciences, Inc. (JBIO)
Drug: jade101
Indication: IgAN

Track this catalyst and more

Get real-time alerts, AI-powered analysis, and full catalyst coverage.

Start Free Full Calendar

Phase 2 Readout: jade101 — JBIO Phase 2 Readout | BioSniper